ABSTRACT Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and death rates are rate from all cancers combined has decreased by 1.5% per year since 1993 among men and by 0.8% per year since 1992 among women. The mortality rate has also continued to decrease for the three most common cancer sites in men (lung and bronchus, colon and rectum, and prostate) and for breast and colon and rectum cancers in women. Lung cancer mortality among women continues to increase slightly. In analyses by race and ethnicity, African American men and women have 40% and 18% higher death rates from all cancers combined than White men and women, respectively. Cancer incidence and death rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden of suffering and death from cancer can be accelerated by applying existing cancer control knowledge across all segments of the population. (CA Cancer J Clin 2006;56:106-130.)
INTRODUCTION
Cancer is a major public health problem in the United States and other developed countries. Currently, one in four deaths in the United States is due to cancer. In this article, we provide an overview of cancer statistics, including updated incidence, mortality, and survival rates and expected number of new cancer cases and deaths in 2006. developing cancer were obtained from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute, covering about 14% of the US population. [2] [3] [4] [5] State-specific incidence rates were abstracted from Cancer in North America (1998) (1999) (2000) (2001) (2002) Volume One, based on data collected by cancer registries participating in the SEER program and Centers for Disease Control and Prevention (CDC)'s National Program of Cancer Registries. Population data were obtained from the US Census Bureau. 6 Causes of death were coded and classified according to the International Classification of Diseases (ICD-8, ICD-9, and ICD-10). [7] [8] [9] Cancer cases were classified according to the International Classification of Diseases for Oncology. 10 
Estimated New Cancer Cases
The precise number of cancer cases diagnosed each year in the nation is unknown because complete cancer registration has not yet been achieved in many states. Consequently, for the national estimate we first estimated the number of new cancer cases occurring annually in the United States from 1979 through 2002, using age-specific cancer incidence rates collected by the SEER program 2 and population data reported by the US Census Bureau. 6 We then forecast the number of cancer cases expected to be diagnosed in the United States in the year 2006 using an autoregressive quadratic time-trend model fitted to the annual cancer case estimates. 11 For estimates of new cancer cases in individual states, we projected the number of deaths from cancer in each state in 2006 and assumed that the ratio of estimated cancer deaths to cases in each state equaled that in the United States.
Estimated Cancer Deaths
We used the state-space prediction method 12 to estimate the number of cancer deaths expected to occur in the United States and in each state in the year 2006. Projections arebased on underlying cause-of-death from death certificates as reported to the NCHS. 1 This model projects the number of cancer deaths expected to occur in 2006 based on the number that occurred each year from 1969 to 2003 in the United States and in each state separately.
Other Statistics
We provide mortality statistics for the leading causes of death as well as deaths from cancer in the year 2003. Causes of death for 2003 were coded and classified according to This report also provides updated statistics on trends in cancer incidence and mortality rates, the probability of developing cancer, and 5-year relative survival rates for selected cancer sites based on data from 1974 through 2002. 3 All age-adjusted incidence and death rates are standardized to the 2000 US standard population and expressed per 100,000 population.
The long-term incidence rates and trends (1975 to 2002) are adjusted for delays in reporting where possible. Delayed reporting affects the most recent 1 to 3 years of incidence data (in this case, 2000 to 2002), especially for cancers such as melanoma and prostate that are frequently diagnosed in outpatient settings. The NCI has developed a method to account for expected reporting delays in SEER registries for all cancer sites combined and several specific cancer sites when long-term incidence trends are analyzed. 13 Delay-adjusted incidence provides a more accurate assessment of trends in the most recent years for which data are available. Table 2 . Figure 1 indicates the most common cancers expected to occur in men and women in 2006. Among men, cancers of the prostate, lung and bronchus, and colon and rectum account for over 56% of all newly diagnosed cancer. Pros- tate cancer alone accounts for about 33% (234,460) of incident cases in men. Based on cases diagnosed between 1995 and 2001, an estimated 91% of these new cases of prostate cancer are expected to be diagnosed at local or regional stages, for which 5-year relative survival approaches 100%.
SELECTED FINDINGS

Expected Numbers of New Cancer Cases
The three most commonly diagnosed cancers among women in 2006 will be cancers of the breast, lung and bronchus, and colon and rectum, accounting for about 54% of estimated cancer cases in women. Breast cancer alone is expected to account for 31% (212,920) of all new cancer cases among women. Table 1 also shows the expected number of cancer deaths in 2006 for men, women, and both sexes combined. It is estimated that about 564,830 Americans will die from cancer, corresponding to over 1,500 deaths per day. Cancers of the lung and bronchus, colon and rectum, and prostate in men, and cancers of the lung and bronchus, breast, and colon and rectum in women continue to be the most common fatal cancers. These four cancers account for half of the total cancer deaths among men and women (Figure 1) . Lung cancer surpassed breast cancer as the leading cause of cancer death in women in 1987. Lung cancer is expected to account for 26% of all cancer deaths among females in 2006. Table 3 provides the estimated number of cancer deaths in 2006 by state for selected cancer sites. Table 4 , the largest variation in the incidence rates (in proportionate terms) occurred in lung cancer in which rates (cases per 100,000 population) ranged from 42.3 in men and 21.5 in women in Utah to 138.2 in men and 72.3 in women in Kentucky. In contrast, the variation in female breast cancer incidence rates was small, ranging from 116.6 cases per 100,000 populations in New Mexico to 149.5 cases in Washington. Factors that contribute to the state variations in the incidence rates include differences in the prevalence of risk factors, access to and utilization of early detection services, and completeness of reporting. For example, the state variation in lung cancer incidence rates reflects differences in smoking prevalence; Utah ranks lowest in adult smoking prevalence and Kentucky highest. 
Expected Number of New Cancer Deaths
Regional Variations in Cancer Rates
Trends in Cancer Incidence and Mortality
Figures 2 to 5 depict long-term trends in cancer incidence and death rates for all cancers combined and for selected cancer sites by sex. Table 5 shows incidence and mortality patterns for all cancer sites and for the four most common cancer sites based on joinpoint analysis. Mortality rates have continued to decrease across all four major cancer sites in men and in women, except for female lung cancer in which rates continued to increase by 0.3% per year from 1995 to 2002 (Table 5 ). The incidence trends are mixed, however. Lung cancer incidence rates are declining in men and have leveled off after increasing for many decades in women. The lag in the temporal trend of lung cancer incidence rates in women compared to men reflects historical differences in cigarette smoking between men and women; cigarette smoking in women peaked about 20 years later than in men. Colorectal cancer incidence rates have decreased from 1998 through 2002 in both males and in females. Prostate and female breast cancer incidence rates have continued to increase, although at a slower rate than in previous years. The continuing increase may be attributable to increased screening through prostate-specific antigen (PSA) testing for prostate cancer and mammography for breast cancer. Use of postmenopausal hormone therapy and increased prevalence of obesity may also be factors influencing the increase in female breast cancer incidence. Cancer accounted for about 23% of all deaths, ranking second only to heart disease ( Table 6 ). When cause of death is ranked within each age group, categorized in 20-year age intervals, cancer is one of the five leading causes of death in each age group among both males and females (Table 7) . Cancer is the leading cause of death among women ages 40 to 79 and among men ages 60 to 79. When age-adjusted death rates are considered ( Figure  6 ), cancer is the leading cause of death among men and women under age 85. A total of 476,844 people under age 85 died from cancer in the US in 2003, compared with 436,258 deaths from heart disease. Table 8 presents the number of deaths from all cancers combined and the five most common cancer sites for males and females at various ages. Among males under age 40, leukemia is the most common cause of cancer death, whereas cancer of the lung and bronchus predominates in men age 40 years and older. Colon and rectum and prostate cancer are the second most common causes of cancer death among men 40 to 79 years old and age 80 years and older, respectively. Among females, leukemia is the leading cause of cancer death before age 20, breast cancer ranks first at ages 20 to 59 years, and lung cancer ranks first at age 60 years and older. Table 9 ). The largest change in the total number of deaths from the major cancers was for prostate cancer in men (decreased by 892) and for lung cancer in women (increased by 575).
CANCER OCCURRENCE BY RACE/ETHNICITY
Cancer incidence and death rates vary considerably among racial and ethnic groups (Table 10). For all cancer sites combined, African American men have a 23% higher incidence rate and 40% higher death rate than White men. African American women have a 7% lower inci-dence rate but an 18% higher death rate than White women for all cancer sites combined. For the specific cancer sites listed in Table 10 , incidence and death rates are consistently higher in African Americans than in Whites, except for breast cancer (incidence) and lung cancer (mortality) among women. Death rates from prostate, stomach, and cervical cancers among African Americans are more than twice those in Whites. Factors known to contribute to racial disparities in mortality include differences in exposure (eg, Helicobacter pylori for stomach cancer), access to high-quality regular screening (breast, cervical, and colorectal cancers), and timely treatment (for many cancers). The higher breast cancer incidence rate among Whites is thought to reflect a combination of factors that affect diagnosis, such as more frequent mammography in White women, and factors that affect disease risk, such as later age at first birth and greater use of hormone replacement therapy among White than African American women. 14 Among other racial and ethnic groups, cancer incidence and death rates are lower for all cancer sites combined and for the four most common cancer sites than are rates in Whites and African Americans. However, incidence and death rates for cancers of the uterine cervix, stomach, and liver are generally higher in minority population than in Whites. Stomach and liver cancer incidence and death rates are more than twice as high in Asian/Pacific Islanders as in Whites, reflecting increased exposure to infectious agents such as H. pylori and Hepatitis B virus. 15 Trends in cancer incidence can only be adjusted for delayed reporting in Whites and African Americans, and not in other racial and ethnic subgroups because the long-term incidence data required for delay adjustment are available only for Whites and for African Americans. From 1992 to 2002, incidence rates for all cancer sites combined, not adjusted for delayed reporting, decreased by 2.7% per year among American Indians/Alaskan Natives, by 1.0% per year in African Americans, by 0.6% among Asian/Pacific Islanders, and by 0.4% among Hispanic-Latinos and Whites. Similarly, the death rate for all cancers combined decreased from 1992 through 2002 by 1.7% per year in Asian/Pacific Islanders, by 1.5% among African Americans, by 0.9% among Whites, and by 0.6% among HispanicLatinos. The death rate from all cancers combined stabilized during this time period among American Indians/Alaskan Natives. 
Lifetime Probability of Developing Cancer
The lifetime probability of developing cancer is higher for men (46%) than for women (38%) (Table 11 ). However, because of the relatively early age of onset of breast cancer, women have a slightly higher probability of developing cancer before the age of 60 years. It is noteworthy that these estimates are based on the average experience of the general population and may over or under estimate individual risk because of differences in exposure and/or genetic susceptibility.
Cancer Survival by Race
Compared with Whites, African American men and women have poorer survival once a cancer diagnosis is made. As shown in Figure 7 , African Americans are less likely than Whites to be diagnosed with cancer at a localized stage, when the disease may be more easily and successfully treated, and are more likely to be diagnosed with cancer at a regional or distant stage of disease. Five-year relative survival is lower in African Americans than Whites within each stratum of stage of diagnosis for nearly every cancer site (Figure 8 ). These disparities may result from inequalities in access to and receipt of quality health care and/or from dif- ferences in comorbidities. The extent to which these factors, individually or collectively, contribute to the overall differential survival is unclear. 16 However, recent findings suggest that African Americans who receive similar cancer treatment and medical care as Whites experience similar outcomes.
17
There have been notable improvements over time in relative five-year survival rates for many cancer sites and for all cancers combined (Table 12 ). This is true for both Whites and African Americans. However, 5-year relative survival is still very poor (less than 25%) for many cancers, including pancreas, liver, esophagus, lung, and stomach.
Relative survival rates cannot be calculated for other racial and ethnic populations because accurate life expectancies are not available. However, based on cause-specific survival rates of cancer patients diagnosed from 1992 to 2000 in SEER areas of the United States, all minority populations, except Asian/Pacific Islander women, have a greater probability of dying from cancer within 5 years of diagnosis than non-Hispanic Whites after accounting for differences in age at diagnosis. 18, 19 For the four major cancer sites (prostate, female breast, lung and bronchus, and colon and rectum), minority populations are more likely to be diagnosed at distant stage, compared with non-Hispanic Whites. 19 
CANCER IN CHILDREN
Cancer is the second leading cause of death among children between the ages of 1 and 14 years in the United States; accidents are the most frequent cause of death in this age group (Table  13) . The most common cancers in children (0 to 14 years) are leukemia (particularly acute lymphocytic leukemia), cancer of the brain and other nervous system, soft tissue sarcomas, nonHodgkin Lymphoma, and renal (Wilms) tumors. 3 Over the past 25 years, there have been significant improvements in the 5-year relative survival rate for many childhood cancers (Table  14) . The 5-year relative survival rate among children for all cancer sites combined improved from 
